Veran Medical has introduced a new navigated catheter and two navigation software applications to help physicians diagnose and guide treatment of early-stage lung cancer lesions.
Image: The new SPiN access catheter will help diagnose and guide treatment of early-stage lung cancer lesions. Photo: courtesy of dream designs / FreeDigitalPhotos.net.
Veran said the new SPiN access catheter is an extended working channel navigated by an Always-On Tip Tracked guidewire.
The catheter will allow lung specialists to provide accurate 3D map for navigation, respiratory gating, and also offers compatibility with Always-On Tip Tracked sampling instruments.
Veran’s new catheter allows more accurate 3D navigation without the support of intraprocedural fluoroscopy during sampling.
Penn Highlands Healthcare’s interventional pulmonologist Sandeep Bansal has carried out first procedures with the new SPiN access catheter.
Bansal said: “The SPiN Access Catheter is a game changer as it provides me with an extended working channel approach but with Veran’s added benefits of more accurate navigation, the ability to track respiration, tip tracked sampling instruments, and the ability to transition to a navigated TTNA, when needed.”
The firm’s next generation SPiN thoracic navigation system provided an advanced precision thoracic guidance platform that enables lung specialists to seamlessly transition between navigated endobronchial approach and navigated transthoracic approach utilizing SPiN Perc, helping physicians diagnose lung cancer earlier.
According to the company, a published clinical study using multi-modality approach, including Veran’s SPiN System and SPiN Perc, has showed 92% diagnostic yield.
The company will exhibit the new navigated catheter and software applications at the CHEST Annual Meeting in San Antonio, Texas.
Veran Medical CEO Jason Pesterfield said: “The expanding adoption of lung cancer screening has given us a real opportunity to catch cancer earlier and save lives, but only if we can help physicians reach the smallest nodules.
“Our new software applications and SPiN Access Catheter provide additional flexibility to help physicians reach and guide treatment for early stage cancer when patients have the best prognosis.”
Based in St. Louis of Missouri, Veran is engaged in the development of advanced solutions for early diagnosis and treatment of lung cancer.
The company supplies a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation.